Immunoglobulin Market 2023-28 | Size, Growth, Trends, Share & Forecast

The global immunoglobulin market size reached US$ 14.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 21.1 Billion by 2028, exhibiting a growth rate (CAGR) of 6% during 2023-2028.

IMARC Group, a leading market research company, has recently released a report titled "Immunoglobulin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028". The study provides a detailed analysis of the industry, including the global immunoglobulin market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

What Are The Growth Prospects Of The Immunoglobulin Industry?

According to the report, The global immunoglobulin market size reached US$ 14.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 21.1 Billion by 2028, exhibiting a growth rate (CAGR) of 6% during 2023-2028.

What is Immunoglobulin?

Immunoglobulins, also known as antibodies, refer to a type of glycoprotein molecule created by plasma or white blood cells (WBC). They are found in the serum and cells of the immune system and function as antibodies by explicitly recognizing and binding antigens such as viruses or bacteria and aiding in their destruction. They help medical professionals diagnose autoimmune diseases, allergies, and immunodeficiencies, such as lupus, celiac disease, and juvenile idiopathic arthritis, by measuring the immunoglobulin level in a blood sample. They are commonly administered through intravenous and subcutaneous routes of delivery. As a result, immunoglobulins are widely used to treat immunological and neurological conditions, including chronic inflammatory demyelinating polyneuropathy (CIDP), hypogammaglobulinemia, and myasthenia gravis.

Request for a free sample copy of this report:

What are the growth prospects and trends in the Immunoglobulin industry?

The market is primarily driven by the growing prevalence of immunodeficiency disorders such as hepatitis, leukemia, and multiple myeloma across the globe. In addition, rapid urbanization, hectic working schedules, sedentary lifestyles, and increasing consumption of fast foods are contributing to the rising burden of several medical conditions, including Waldenstrom macroglobulinemia and autoimmune disorders. Moreover, the recent onset of the coronavirus (COVID-19) pandemic resulted in the escalating demand for hyperimmune globulin as an effective medicine to manage the disease among hospitalized patients, which represents another major growth-inducing factor. Besides this, the rising awareness regarding early diagnosis and personalized medicines and the widespread adoption of immunoglobulins to help the body fight infectious diseases are accelerating market growth. Furthermore, several leading pharmaceutical companies are introducing new and advanced immunoglobulins with improved efficacy to treat neurological disorders and are extensively investing in research and development (RD) activities, which in turn is creating a positive market outlook.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Product:

  • IgG
  • IgA
  • IgM
  • IgE
  • IgD

Breakup by Application:

  • Hypogammaglobulinemia
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • Immunodeficiency Disease
  • Myasthenia Gravis
  • Others

Breakup by Mode of Delivery:

  • Intravenous Mode of Delivery
  • Subcutaneous Mode of Delivery

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • ADMA Biologics Inc.
  • Baxter international Inc.
  • Biotest AG
  • CSL Limited
  • Grifols S.A
  • Kedrion S.p.A
  • LFB SA
  • Octapharma AG
  • Sanquin Plasma Products B.V.
  • Takeda Pharmaceutical Company Limited.

Ask Analyst for Customization and Browse full report with TOC List of Figure:

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US



USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA

Follow us on Twitter: @imarcglobal